[go: up one dir, main page]

DE60129151D1 - Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) - Google Patents

Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)

Info

Publication number
DE60129151D1
DE60129151D1 DE60129151T DE60129151T DE60129151D1 DE 60129151 D1 DE60129151 D1 DE 60129151D1 DE 60129151 T DE60129151 T DE 60129151T DE 60129151 T DE60129151 T DE 60129151T DE 60129151 D1 DE60129151 D1 DE 60129151D1
Authority
DE
Germany
Prior art keywords
callique
human
detecting
detecting egg
binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60129151T
Other languages
English (en)
Other versions
DE60129151T2 (de
Inventor
Eleftherios P Diamandis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mt Sinai Hospital
Original Assignee
Mt Sinai Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mt Sinai Hospital filed Critical Mt Sinai Hospital
Application granted granted Critical
Publication of DE60129151D1 publication Critical patent/DE60129151D1/de
Publication of DE60129151T2 publication Critical patent/DE60129151T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G01N33/57545—
    • G01N33/57585—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96455—Kallikrein (3.4.21.34; 3.4.21.35)

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60129151T 2000-10-27 2001-10-26 Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) Expired - Lifetime DE60129151T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24378900P 2000-10-27 2000-10-27
US243789P 2000-10-27
PCT/CA2001/001505 WO2002035232A2 (en) 2000-10-27 2001-10-26 Method for detecting ovarian cancer based on human kallikrein 6 (hk6)

Publications (2)

Publication Number Publication Date
DE60129151D1 true DE60129151D1 (de) 2007-08-09
DE60129151T2 DE60129151T2 (de) 2008-03-06

Family

ID=22920140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60129151T Expired - Lifetime DE60129151T2 (de) 2000-10-27 2001-10-26 Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)

Country Status (9)

Country Link
US (1) US20040096915A1 (de)
EP (1) EP1330652B1 (de)
JP (1) JP2004511810A (de)
AT (1) ATE365922T1 (de)
AU (1) AU2002213704A1 (de)
CA (1) CA2426286A1 (de)
DE (1) DE60129151T2 (de)
ES (1) ES2287169T3 (de)
WO (1) WO2002035232A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022497B1 (en) * 1999-03-11 2006-04-04 Mt. Sinai Hospital Human kallikrein-like genes
AU2001287384B2 (en) * 2000-08-11 2007-03-29 Mount Sinai Hospital Kallikrein gene
CA2426571A1 (en) * 2000-11-01 2002-05-10 Eleftherios P. Diamandis Detection of ovarian cancer
CA2448355A1 (en) * 2001-05-25 2002-12-05 Mount Sinai Hospital Method of detecting and monitoring prostate and ovarian cancers
WO2003034068A1 (en) * 2001-10-16 2003-04-24 Mount Sinai Hospital Localization of disorders associated with kallikreins
JP2005505303A (ja) * 2001-10-16 2005-02-24 マウント・サイナイ・ホスピタル 卵巣癌の検出方法
WO2004021008A2 (en) * 2002-08-28 2004-03-11 Mount Sinai Hospital Methods for detecting breast and ovarian cancer
AU2003266038A1 (en) * 2002-08-28 2004-03-19 Mount Sinai Hospital Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
AU2003271456A1 (en) * 2002-09-26 2004-04-19 Mount Sinai Hospital Methods for detecting endocrine cancer
CA2516591A1 (en) * 2003-02-26 2004-09-10 Mount Sinai Hospital Multiple marker assay for detection of ovarian cancer
WO2004077060A2 (en) * 2003-02-27 2004-09-10 Mount Sinai Hospital Assay for detection of renal cell carcinoma
US20050106586A1 (en) * 2003-06-13 2005-05-19 Mount Sinai Hospital Detection of neurodegenerative diseases
US20060269971A1 (en) * 2003-09-26 2006-11-30 Mount Sinai Hospital Methods for detecting prostate cancer
CN1922332B (zh) * 2003-12-31 2013-06-12 宾夕法尼亚州研究基金会 预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法
WO2005078117A2 (en) * 2004-02-18 2005-08-25 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6)
DE102005004294A1 (de) * 2005-01-28 2006-08-03 Bayer Healthcare Ag Auswahl und Bewertung diagnostischer Tests mittels Diskordanzanalysen-Charakteristik (DAC)
CA2703795A1 (en) 2006-10-27 2008-05-02 Mount Sinai Hospital Endometrial phase or endometrial cancer biomarkers
WO2009126455A1 (en) * 2008-04-09 2009-10-15 Smiths Detection Inc. Multi-dimensional spectral analysis for improved identification and confirmation of radioactive isotopes
US7851230B2 (en) * 2008-04-14 2010-12-14 Chang Gung Memorial Hospital Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
EP2524059A4 (de) 2010-01-13 2013-11-20 Caris Life Sciences Luxembourg Holdings Detektion von gastrointestinalen erkrankungen
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
EP2721417A4 (de) * 2011-06-17 2015-05-06 Univ Arkansas Neue marker zur frühdiagnose von eierstockkrebs, überwachung während der entsprechenden therapie und neue therapieoptionen während und nach der entsprechenden chemotherapie
CN103675278A (zh) * 2013-11-19 2014-03-26 上海裕隆医学检验所股份有限公司 一种糖链抗原125定量检测试剂盒及其应用
CA2964367C (en) 2014-10-14 2024-01-30 Novartis Ag Antibody molecules to pd-l1 and uses thereof
IL311084A (en) 2018-11-30 2024-04-01 Caris Mpi Inc New generation molecular characterization
WO2021112918A1 (en) 2019-12-02 2021-06-10 Caris Mpi, Inc. Pan-cancer platinum response predictor

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660827A (en) * 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
IL105793A0 (en) * 1992-05-28 1993-09-22 Lilly Co Eli Protease and related dna compounds
WO1998011238A2 (en) * 1996-09-13 1998-03-19 Dana-Farber Cancer Institute Protease m, a novel serine protease
US6294344B1 (en) * 1997-03-19 2001-09-25 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US6870027B2 (en) * 1997-03-19 2005-03-22 O'brien Timothy J. Methods for the early diagnosis of ovarian cancer
US6268165B1 (en) * 1997-03-19 2001-07-31 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
US6316213B1 (en) * 1997-03-19 2001-11-13 The Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian, breast and lung cancer
WO1998041656A1 (en) * 1997-03-19 1998-09-24 The Board Of Trustees Of The University Of Arkansas Compositions and method for the early diagnosis of ovarian cancer
ES2273496T3 (es) * 1998-07-02 2007-05-01 Fuso Pharmaceutical Industries, Ltd. Anticuerpos monoclonales que se unen especificamente a una serina proteasa y utilizacion de los mismos.
US6942978B1 (en) * 1999-03-03 2005-09-13 The Board Of Trustees Of The University Of Arkansas Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
US7022497B1 (en) * 1999-03-11 2006-04-04 Mt. Sinai Hospital Human kallikrein-like genes
US7935531B2 (en) * 2000-02-22 2011-05-03 Board Of Trustees Of The University Of Arkansas Methods for the early diagnosis of ovarian cancer
AU2001287384B2 (en) * 2000-08-11 2007-03-29 Mount Sinai Hospital Kallikrein gene
US6962793B2 (en) * 2000-10-27 2005-11-08 Mount Sinai Hospital Methods for detecting Alzheimers disease
CA2448355A1 (en) * 2001-05-25 2002-12-05 Mount Sinai Hospital Method of detecting and monitoring prostate and ovarian cancers
JP2005505303A (ja) * 2001-10-16 2005-02-24 マウント・サイナイ・ホスピタル 卵巣癌の検出方法
AU2003213960A1 (en) * 2002-04-04 2003-10-20 Mount Sinai Hospital Methods for detecting ovarian cancer
US20040015745A1 (en) * 2002-07-22 2004-01-22 Finisar Corporation Scalable socketed testing tool
WO2004021008A2 (en) * 2002-08-28 2004-03-11 Mount Sinai Hospital Methods for detecting breast and ovarian cancer
AU2003266038A1 (en) * 2002-08-28 2004-03-19 Mount Sinai Hospital Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
AU2003271456A1 (en) * 2002-09-26 2004-04-19 Mount Sinai Hospital Methods for detecting endocrine cancer
CA2516591A1 (en) * 2003-02-26 2004-09-10 Mount Sinai Hospital Multiple marker assay for detection of ovarian cancer
WO2004077060A2 (en) * 2003-02-27 2004-09-10 Mount Sinai Hospital Assay for detection of renal cell carcinoma
US20050106586A1 (en) * 2003-06-13 2005-05-19 Mount Sinai Hospital Detection of neurodegenerative diseases
US20060269971A1 (en) * 2003-09-26 2006-11-30 Mount Sinai Hospital Methods for detecting prostate cancer

Also Published As

Publication number Publication date
US20040096915A1 (en) 2004-05-20
AU2002213704A1 (en) 2002-05-06
ATE365922T1 (de) 2007-07-15
ES2287169T3 (es) 2007-12-16
JP2004511810A (ja) 2004-04-15
WO2002035232A2 (en) 2002-05-02
EP1330652B1 (de) 2007-06-27
DE60129151T2 (de) 2008-03-06
WO2002035232A3 (en) 2002-09-26
CA2426286A1 (en) 2002-05-02
EP1330652A2 (de) 2003-07-30

Similar Documents

Publication Publication Date Title
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
KR101764597B1 (ko) 생물학적 샘플에서 희귀 사건 분석을 위한 고감도 다중매개변수 방법
SG169395A1 (en) Detection of cancer by elevated levels of bcl-2
DK1734368T3 (da) Annexin-autoantistoffer anvendt som markörer for lungecancer
PH12020551371A1 (en) Assays to detect neurodegeneration
CA2384579A1 (en) Early cancer tumor marker
DE60300339D1 (de) Verfahren zum Nachweis von Karzinomen in solubilisierten zervikalen Körperproben
DE60033555D1 (de) Verfahren und zusammestellungen zum nachweis und behandlung von brustkrebs, beruhend auf brustkrebs-assoziierten polypeptiden
DE60207979D1 (de) Verfahren und Vorrichtung zur Bestimmung der Gewebespezifität von freier DNA in Körperflüssigkeiten
ATE425266T1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
WO2004055519A3 (en) Specific markers for pancreatic cancer
ATE267399T1 (de) Verfahren zum nachweis von komplex-gebundenem prostata-spezifischem antigen (kpsa)
DE60025347D1 (de) Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
CA2623653A1 (en) Use of n-myristoyltransferase on non-tumor tissue for cancer diagnosis
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
WO2002004952A3 (en) Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors
WO2002063048A3 (en) Methods for predicting sensitivity of tumors to arginine deprivation
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
TW200510725A (en) Diagnostic kit for liver cirrhosis comprising an antibody specific for human proto oncogenic protein
WO2008036474A3 (en) A method to detect tumor markers and diagnosis of undifferenciated tumors
WO2007060240A3 (fr) Procede pour la mise en evidence de la presence ou de l ' absence de marquers (eef1a1 ou mark3 ) associes a la presence et/ou a la chimiosensibilite des tumeurs
GB9913819D0 (en) Assay

Legal Events

Date Code Title Description
8364 No opposition during term of opposition